Duran i Reynals Hospital
Hospital
Location:
Barcelona,
Spain (ES)
ISNI: -
ROR: https://ror.org/03qwghy04
Show on Map:
Results from CONTESSA: A phase 3 study of tesetaxel plus a reduced dose of capecitabine versus capecitabine alone in patients with HER2-, hormone receptor plus (HR plus ) metastatic breast cancer (MBC) who have previously received a taxane (2021)
O'Shaughnessy J, Schwartzberg L, Piccart M, Rugo HS, Yardley DA, Cortes J, Untch M, et al.
Conference contribution
Portfolio of prospective clinical trials including brachytherapy: an analysis of the ClinicalTrials.gov database (2016)
Cihoric N, Tsikkinis A, Miguelez CG, Strnad V, Soldatovic I, Ghadjar P, Jeremic B, et al.
Journal article